Latest Breaking News On - Jon congleton - Page 4 : comparemela.com

$5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying - Burke & Herbert Financial (NASDAQ:BHRB), Mineralys Therapeutics (NASDAQ:MLYS)

Although U.S. stocks closed higher on Friday, there were a few notable insider trades.

United statesLoudoun countyMarkg andersonJon congletonJohnb sanfilippoTreehouse foods incTreehouse foodsSummit financial groupJana partnersBurke herbert financial services corpBurke herbert financial servicesMineralys therapeutics incTreehouse foods doesHerbert financial servicesHerbert financial services doesHerbert financial services corp

Mineralys Therapeutics to Participate in the Cantor Fitzgerald Global Healthcare Conference on Thursday, September 28, 2023

Mineralys Therapeutics to Participate in the Cantor Fitzgerald Global Healthcare Conference on Thursday, September 28, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJon congletonTom weibleCatalys pacificAdam levyElixir health public relationsMineralys therapeutics incCantor fitzgerald global healthcare conferenceChief executive officer jon congletonChief financial officerChief business officerNew yorkFitzgerald global healthcare conferenceInvestor relationsMineralys therapeutics

Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results in Late-Breaking Science Session at 2023 AHA Hypertension Scientific Sessions

– Lorundrostat, a highly selective aldosterone synthase inhibitor, demonstrated robust, double-digit reduction in systolic blood pressure , including an enhanced response in individuals with.

United statesTom weibleTanabe pharmaCatalys pacificJon congletonElixir health public relationsDrug administrationMineralys therapeutics incGlobenewswire incAmerican heart associationJournal of the american medical associationExchange commissionAmerican medical associationHeart associationHypertension scientific sessionsChief executive officer

Mineralys Therapeutics, Inc (NASDAQ:MLYS) Receives Consensus Rating of Buy from Analysts

Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have covered the stock […]

United statesNew yorkDavid malcom rodmanJon congletonCitigroup incCredit suisse groupMineralys therapeutics company profileWells fargo companyYork state common retirement fundMineralys therapeutics incMineralys therapeuticsGet free reportSuisse groupState teachers retirement systemWells fargoGet free

Sectoral Asset Management Inc Takes $9 60 Million Position in Mineralys Therapeutics, Inc (NASDAQ:MLYS)

Sectoral Asset Management Inc Takes $9 60 Million Position in Mineralys Therapeutics, Inc (NASDAQ:MLYS)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesDavid malcom rodmanJon congletonMineralys therapeutics company profileBarclays plcMonashee investment managementMineralys therapeutics incYork mellon corpSectoral asset management incCredit suisse groupSectoral asset managementMineralys therapeuticsFree reportAsset managementInvestment managementState teachers retirement system